✦ LIBER ✦

A RANDOMISED STUDY EVALUATING MAINTENANCE SCHEDULE IN EARLY ADJUVANT CHEMOTHERAPY FOR INTERMEDIATE RISK NON-MUSCLE-INVASIVE BLADDER CANCER

✍ Scribed by V. Serretta; V. Altieri; G. Morgia; P. Annese; G. Carrieri; A. Zito; A. Di Lallo; G. Ruggiero; L. Salzano; F. Nicolosi; N.S. Simone; F. Vacirca; M. Pavone-Macaluso; F.P. Selvaggi; G. Coraci; R. Allegro; D. Melloni

Book ID: 119619238
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 73 KB
Volume: 7
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(08)60907-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A 1-year maintenance after early adjuvan

A 1-year maintenance after early adjuvant intravesical chemotherapy has a limited efficacy in preventing recurrence of intermediate risk non-muscle-invasive bladder cancer

✍ Vincenzo Serretta; Giuseppe Morgia; Vincenzo Altieri; Alessandra Di Lallo; Giova 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB

EFFICACY OF ONE-YEAR MAINTENANCE IN EARL

EFFICACY OF ONE-YEAR MAINTENANCE IN EARLY ADJUVANT CHEMOTHERAPY FOR INTERMEDIATE RISK NON-MUSCLE- INVASIVE BLADDER CANCER. RESULTS AT 24 MONTHS OF A RANDOMIZED TRIAL

✍ Serretta, Vincenzo; Altieri, Vincenzo; Morgia, Giuseppe; Melloni, Darvinio; Kari 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 122 KB

Re: A 1-Year Maintenance After Early Adj

Re: A 1-Year Maintenance After Early Adjuvant Intravesical Chemotherapy has a Limited Efficacy in Preventing Recurrence of Intermediate Risk Non-Muscle-Invasive Bladder Cancer

✍ Wood, David P. 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 58 KB

1467 MAINTENANCE IS OF LIMITED EFFICACY

1467 MAINTENANCE IS OF LIMITED EFFICACY AFTER EARLY ADJUVANT CHEMOTHERAPY FOR INTERMEDIATE RISK NON-MUSCLE INVASIVE BLADDER CANCER. RESULTS AT 48 MONTHS OF A RANDOMIZED TRIAL

✍ Serretta, Vincenzo; Altieri, Vincenzo; Morgia, Giuseppe; Melloni, Darvinio; Zito 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 44 KB

149 THREE SCHEDULES OF ADJUVANT INTRAVES

149 THREE SCHEDULES OF ADJUVANT INTRAVESICAL EPIRUBICIN IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER: A COMPARATIVE STUDY

✍ K. Hendricksen; L.A. Kiemeney; C. Caris; R. Janzing; W. Witjes; J.A. Witjes 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 316 KB

1669 INTRAVESICAL ADJUVANT ELECTROMOTIVE

1669 INTRAVESICAL ADJUVANT ELECTROMOTIVE MITOMYCIN-C IN PATIENTS WITH INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER A RANDOMIZED CONTROLLED TRIAL

✍ Di Stasi, Savino Mauro; Verri, Cristian; Liberati, Emanuele; Micali, Francesco; 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 47 KB